The Bio Report: Taking a Portfolio Approach to Immuno-Oncology Media CoverageBy Portage Biotech, IncAugust 5, 2021...
Empowered Patient Podcast: Stimulating Invariant Natural Killer T-Cells to Boost Immune System in Fight Against Cancer Media CoverageBy Portage Biotech, IncMay 25, 2021...
Portage Biotech Begins Phase I Trial of Invariant Natural Killer T-Cell Therapy Media CoverageBy Dedrian KershawApril 8, 2021...
Juvenescence CEO reveals why its deal with Portage is the smart choice for its longevity IP portfolio Media CoverageBy Dedrian KershawMarch 9, 2021...
CEO Ian Walters Discusses Expectations for Portage Biotech (PRTG) Pipeline Media CoverageBy Dedrian KershawMarch 3, 2021...
Portage Biotech to begin trading its shares on the Nasdaq February 25th Media CoverageBy Dedrian KershawFebruary 22, 2021...
CEO Spotlight: Portage Biotech CEO Dr. Ian Walters Talks Asset Pipeline, Uplist, and Strategic Initiatives in a $20 Billion Sector Media CoverageBy Dedrian KershawDecember 1, 2020...
